Last reviewed · How we verify
Novolin 30R;Pioglitazone;Metformin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Novolin 30R;Pioglitazone;Metformin (Novolin 30R;Pioglitazone;Metformin) — Qianfoshan Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Novolin 30R;Pioglitazone;Metformin TARGET | Novolin 30R;Pioglitazone;Metformin | Qianfoshan Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Novolin 30R;Pioglitazone;Metformin CI watch — RSS
- Novolin 30R;Pioglitazone;Metformin CI watch — Atom
- Novolin 30R;Pioglitazone;Metformin CI watch — JSON
- Novolin 30R;Pioglitazone;Metformin alone — RSS
Cite this brief
Drug Landscape (2026). Novolin 30R;Pioglitazone;Metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/novolin-30r-pioglitazone-metformin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab